Arieli Ran
Corresponding author: The Israel Naval Medical Institute, Israel Defence Forces Medical Corps, Haifa, Israel; Eliachar Research Laboratory, Western Galilee Medical Centre, Nahariya, Israel, 12 Klil-Hakhoresh, Rakefet, D.N. Misgav 2017500, Israel,
Diving Hyperb Med. 2018 Sep 30;48(3):197. doi: 10.28920/dhm48.3.197.
In a study of the effect of a fatty diet on decompression bubbles, based on the responses to a questionnaire regarding daily food consumption, the approximate fat intake for each diver was calculated, taking into account the maximum recommended intake for a person doing his type of work. Following hyperbaric exposure, divers were divided into two groups: 'bubblers' (a minimum of the second level on the Kisman-Masurel scale) and 'non-bubblers'. Bubblers had higher fat consumption than non-bubblers (146 ± 39% versus 92 ± 18%). There was only a small difference in body mass index between the two groups: 26.3 ± 3.3 kg·m⁻² for bubblers and 24.9 ± 1.9 kg·m⁻² for non-bubblers. Cholesterol and triglycerides in serum were high in the bubblers (211 ± 39 mg·dl⁻¹ and 230 ± 129 mg∙dl⁻¹, respectively) compared with the non-bubblers (188 ± 34 mg∙dl⁻¹ and 153 ± 111 mg∙dl⁻¹, respectively). The authors concluded that a high-fat diet significantly increased the severity of decompression stress in hyperbaric air exposures. However, their explanation that the increased amount of fat in the serum contained more dissolved nitrogen, and that this was the cause of the increase in bubble production, was challenged in a subsequent letter. Decompression bubbles can expand and develop only from pre-existing gas micronuclei. It is known that nanobubbles form spontaneously when a smooth hydrophobic surface is submerged in water containing dissolved gas. We have shown that these nanobubbles are the gas micronuclei underlying decompression bubbles and decompression sickness. It has been suggested that hydrophobic multilayers of phospholipids on the luminal aspect of blood vessels, which we have termed active hydrophobic spots (AHS), were derived from lung surfactant. The essential components of lung surfactant required to construct the surfactant films, namely dipalmitoylphosphatidylcholine (DPPC) and surfactant proteins B and C, were found in the plasma of man and sheep, while DPPC was also found at the AHS. These findings have borne out the assumption that lung surfactants are the source of the AHS on the luminal aspect of blood vessels. These AHS seem to be stable, and their number and size increase with age as more DPPC settles. Bubbles may evolve at these AHS with decompression. The nanobubbles so formed on the surface of these lamellar layers of phospholipids in divers will expand into venous bubbles on decompression. The main surfactant in the lung is DPPC (40%), with the presence of additional components including other phospholipids, glycerides, and cholesterol. In the cited study, only serum triglycerides and cholesterol were measured, whereas it may well be that other phospholipids and fatty acids were carried by proteins in the plasma. We suggest that, as with the different elements which compose the layers of surfactant in the lung, some of the additional fatty components carried by the blood will attach themselves to the AHS, thus contributing further to their enlargement. We hypothesise that divers who consume food that is high in fat, and as a result have more fatty components in their blood, will develop more and larger AHS, subsequently becoming bubblers with a higher risk of decompression illness.
在一项关于高脂饮食对减压气泡影响的研究中,根据潜水员对每日食物消耗情况问卷的回答,考虑到从事其工作类型的人推荐的最大摄入量,计算出每个潜水员的大致脂肪摄入量。高压暴露后,潜水员被分为两组:“气泡产生者”(在基斯曼 - 马叙雷尔量表上至少达到二级)和“无气泡产生者”。气泡产生者的脂肪消耗量高于无气泡产生者(分别为146±39%和92±18%)。两组之间的体重指数差异很小:气泡产生者为26.3±3.3kg·m⁻²,无气泡产生者为24.9±1.9kg·m⁻²。与无气泡产生者相比,气泡产生者血清中的胆固醇和甘油三酯较高(分别为211±39mg·dl⁻¹和230±129mg∙dl⁻¹),无气泡产生者分别为188±34mg∙dl⁻¹和153±111mg∙dl⁻¹。作者得出结论,高脂饮食显著增加了高压空气暴露时减压应激的严重程度。然而,他们关于血清中脂肪量增加含有更多溶解氮,这是气泡产生增加原因的解释,在随后的一封信中受到了质疑。减压气泡只能从预先存在的气体微核中膨胀和发展。众所周知,当光滑的疏水表面浸没在含有溶解气体的水中时,纳米气泡会自发形成。我们已经表明,这些纳米气泡是减压气泡和减压病的基础气体微核。有人提出,血管腔内表面的磷脂疏水多层结构,我们称之为活性疏水斑(AHS),源自肺表面活性物质。构建表面活性物质膜所需的肺表面活性物质的基本成分,即二棕榈酰磷脂酰胆碱(DPPC)以及表面活性蛋白B和C,在人和羊的血浆中都有发现,同时在AHS处也发现了DPPC。这些发现证实了肺表面活性物质是血管腔内表面AHS来源的假设。这些AHS似乎是稳定的,随着更多DPPC沉淀,它们的数量和大小会随着年龄增长而增加。减压时气泡可能在这些AHS处形成。潜水员中在这些磷脂层状表面形成的纳米气泡在减压时会膨胀成静脉气泡。肺中的主要表面活性物质是DPPC(40%),还存在包括其他磷脂、甘油酯和胆固醇在内的其他成分。在引用的研究中,只测量了血清甘油三酯和胆固醇,而很可能血浆中的蛋白质携带了其他磷脂和脂肪酸。我们认为,就像构成肺表面活性物质层的不同成分一样,血液携带的一些额外脂肪成分会附着在AHS上,从而进一步促使其增大。我们假设,食用高脂肪食物从而血液中含有更多脂肪成分的潜水员,会形成更多更大的AHS,随后成为气泡产生者,患减压病的风险更高。